FENNEC PHARMACEUTICALS INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 09/30/23 | FY 12/31/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $44.6 | $47.5 | $23.8 | — | $1.8 |
| Operating income | -$6.3 | $2.6 | -$12.8 | — | -$22.6 |
| Net income | -$9.7 | -$0.4 | -$16.0 | — | -$23.7 |
| Balance Sheet | |||||
| Total debt | — | $18.2 | $30.0 | — | $25.0 |
| Cash Flow Statement | |||||
| Free cash flow | — | — | — | — | -$18.2 |
Shares outstanding 35.1M · Free float 77.3%
Annual filing data through FY ended December 31, 2025; float as of September 26, 2026.